Clinical Comparison of Remifentanil TCI Models: Eleveld vs Minto
This study compares the Eleveld and Minto TCI models for remifentanil to assess differences in analgesia levels.
Phase III
Anesthesia / Opioids
Status
Active
Signal Score
6.8
Signal assessment
Signal strength
moderate
Confidence level
moderate
Strategic implication
Strategic teams should monitor the outcomes to evaluate potential shifts in standard practices for opioid administration during anesthesia.
Why it matters
The clinical comparison of the Eleveld and Minto TCI models for remifentanil could lead to significant shifts in anesthesia practices, potentially favoring the Eleveld model. This may impact the competitive landscape for opioid administration in anesthesia, necessitating close observation by pharma strategy teams.
Recommended action
Humanexa recommends Monitor.
Analysis
Results from the trial regarding the effectiveness and safety of the Eleveld model compared to Minto.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.